Choosing Therapy for Hypertrophic Obstructive Cardiomyopathy in the Era of Cardiac Myosin Inhibitors

  Рет қаралды 91

The Texas Heart Institute

The Texas Heart Institute

3 ай бұрын

Ajith Nair, MD presents during the Clinical Trials and Innovation at The Texas Heart Institute session at the Third Annual Global Cardiovascular Forum.
The Texas Heart Institute hosted this educational offering on January 20, 2024.
More information: www.texasheart.org/globalforum2024
01:05 Overview & Myosin Inhibitors
04:39 Trials, Results & Safety
09:15 Treatment & Future Directions

Пікірлер
Hamid Afshar, MD | Cardiac Contractility Modulation (CCM)
26:27
The Texas Heart Institute
Рет қаралды 140
Why Is He Unhappy…?
00:26
Alan Chikin Chow
Рет қаралды 63 МЛН
Evolution of Cardiac Diagnostics: A New Era with AI-Powered FFR-CT
1:20:36
Dr. Pradip Jamnadas, MD
Рет қаралды 368 М.
Joanna Molina-Razavi, MD | Cardiac Neuro Ablation
25:07
The Texas Heart Institute
Рет қаралды 82
Hypertrophic Cardiomyopathy (HOCM) | Cardiology Series
26:33
Medicosis Perfectionalis
Рет қаралды 20 М.
Shreela Sharma, PhD, RDN, LD | Changing Dietary Habits at the Population Level
50:43
Atrial Fibrillation | Clinical Medicine
37:58
Ninja Nerd
Рет қаралды 32 М.
Michael Gold, MD, PhD | Subcutaneous ICD
30:40
The Texas Heart Institute
Рет қаралды 65
11) Heart failure with preserved ejection fraction.
37:57
Heart Failure Fellow Lecture Series
Рет қаралды 840